메뉴 건너뛰기




Volumn 22, Issue 2, 2009, Pages 203-207

Nephrogenic systemic fibrosis: An unsolved riddle

Author keywords

Gadolinium; Lanthanum; Nephrogenic systemic fibrosis

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOFOSVESET; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOVERSETAMIDE; GADOXETIC ACID; LANTHANUM CARBONATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

EID: 67649405172     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (7)

References (31)
  • 3
    • 34548671875 scopus 로고    scopus 로고
    • Gadolinium-enhanced MR imaging and Nephrogenic Systemic Fibrosis: Retrospective study of a renal replacement therapy cohort
    • Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and Nephrogenic Systemic Fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:168-175.
    • (2007) Radiology , vol.245 , pp. 168-175
    • Collidge, T.A.1    Thomson, P.C.2    Mark, P.B.3
  • 4
    • 34347340885 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: Population study examining the relationship of disease development to gadolinium exposure
    • Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol. 2007;2:200-202.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 200-202
    • Deo, A.1    Fogel, M.2    Cowper, S.E.3
  • 5
    • 43049114497 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis associated with gadolinium-based contrast agents: A summary of the medical literature reporting
    • doi:10.1016/ejrad.2008.2.011
    • Broome DR. Nephrogenic systemic fibrosis associated with gadolinium-based contrast agents: a summary of the medical literature reporting. Eur J Radiol. 2008;66:230-234. doi:10.1016/ejrad.2008.2.011.
    • (2008) Eur J Radiol , vol.66 , pp. 230-234
    • Broome, D.R.1
  • 7
    • 3042703080 scopus 로고    scopus 로고
    • Presence of CD45RO+ CD34* cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: A new pathogenic hypothesis
    • Ortonne N, Lipsker D, Chantrel F, Bohem N, Grosshans E, Cribier B. Presence of CD45RO+ CD34* cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol. 2004;150:1050-1052.
    • (2004) Br J Dermatol , vol.150 , pp. 1050-1052
    • Ortonne, N.1    Lipsker, D.2    Chantrel, F.3    Bohem, N.4    Grosshans, E.5    Cribier, B.6
  • 8
    • 33746823044 scopus 로고    scopus 로고
    • Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy
    • Swaminathan S, Ahmed I, Mc Carthy JT. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med. 2006;145:234-235.
    • (2006) Ann Intern Med , vol.145 , pp. 234-235
    • Swaminathan, S.1    Ahmed, I.2    Mc Carthy, J.T.3
  • 9
    • 34247889994 scopus 로고    scopus 로고
    • Safety update on the possible casual relationship between gadolinium-containing-MRI agents and nephrogenic systemic fibrosis
    • Pedersen M. Safety update on the possible casual relationship between gadolinium-containing-MRI agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 2007;25:881-883.
    • (2007) J Magn Reson Imaging , vol.25 , pp. 881-883
    • Pedersen, M.1
  • 10
    • 33846223894 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: A review of 6 cases temporally related to gadodiamide injection (Omniscan)
    • Khurana A, Runge VM, Naranayan M, Greene JF Jr, Nickel AE. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan). Radiology. 2007;42:139-145.
    • (2007) Radiology , vol.42 , pp. 139-145
    • Khurana, A.1    Runge, V.M.2    Naranayan, M.3    Greene Jr, J.F.4    Nickel, A.E.5
  • 11
    • 33847239121 scopus 로고    scopus 로고
    • Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
    • Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-649.
    • (2007) Radiology , vol.242 , pp. 647-649
    • Kuo, P.H.1    Kanal, E.2    Abu-Alfa, A.K.3    Cowper, S.E.4
  • 12
    • 34247230130 scopus 로고    scopus 로고
    • Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency
    • Chewning RH, Murphy KJ. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency. J Vasc Interv Radiol. 2007;18:331-334.
    • (2007) J Vasc Interv Radiol , vol.18 , pp. 331-334
    • Chewning, R.H.1    Murphy, K.J.2
  • 16
    • 33845879909 scopus 로고    scopus 로고
    • Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
    • Jan;
    • High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. Am Acad Dermatol. 2007 Jan;56(1):21-6.
    • (2007) Am Acad Dermatol , vol.56 , Issue.1 , pp. 21-26
    • High, W.A.1    Ayers, R.A.2    Chandler, J.3    Zito, G.4    Cowper, S.E.5
  • 17
    • 33847248060 scopus 로고    scopus 로고
    • Nephrogenic fibrosis dermopathy associated with exposure to gadolinium-containing contrast agents: St Louis, Missouri, 2002-2006
    • Centers for Disease Control and Prevention CDC
    • Centers for Disease Control and Prevention (CDC). Nephrogenic fibrosis dermopathy associated with exposure to gadolinium-containing contrast agents: St Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep. 2007;56:137-141.
    • (2007) MMWR Morb Mortal Wkly Rep , vol.56 , pp. 137-141
  • 18
    • 33748049106 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
    • Marckmann P, Skov L, Rossen K. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17:2359-2362.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2359-2362
    • Marckmann, P.1    Skov, L.2    Rossen, K.3
  • 19
    • 34548358966 scopus 로고    scopus 로고
    • Gadolinium is not the only trigger for nephrogenic systemic fibrosis: Insights from two cases and review of the recent literature
    • Wahba IM, Simpson EL, White K. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant. 2007;7:2425-2432.
    • (2007) Am J Transplant , vol.7 , pp. 2425-2432
    • Wahba, I.M.1    Simpson, E.L.2    White, K.3
  • 20
    • 34147193807 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: Risk factors and incidence estimation
    • Sadowski EA, Bennet LK, Chan MR. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
    • (2007) Radiology , vol.243 , pp. 148-157
    • Sadowski, E.A.1    Bennet, L.K.2    Chan, M.R.3
  • 21
    • 33846525037 scopus 로고    scopus 로고
    • A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis
    • Weiss AS, Lucia MS, Teitelbaum I. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis. Nat Clin Pract Nephrol. 2007;3:111-115.
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 111-115
    • Weiss, A.S.1    Lucia, M.S.2    Teitelbaum, I.3
  • 23
    • 0742287030 scopus 로고    scopus 로고
    • Nephrogenic fibrosing dermopathy: The first 6 years
    • Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol. 2003;15:785-790.
    • (2003) Curr Opin Rheumatol , vol.15 , pp. 785-790
    • Cowper, S.E.1
  • 24
    • 34250667094 scopus 로고    scopus 로고
    • Hyperphosphatemia in dialysis patients: The therapeutic role of lanthanum carbonate
    • Cozzolino M, Brancaccio D. Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate. Int J Artif Organs. 2007;30:293-300.
    • (2007) Int J Artif Organs , vol.30 , pp. 293-300
    • Cozzolino, M.1    Brancaccio, D.2
  • 25
    • 32844457995 scopus 로고    scopus 로고
    • Progressive accumulation of lanthanum in the liver of normal and uremic rats
    • Slatopolsky E, Liapis H, Finch J. Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int. 2006;68:2809-2813.
    • (2006) Kidney Int , vol.68 , pp. 2809-2813
    • Slatopolsky, E.1    Liapis, H.2    Finch, J.3
  • 26
    • 35349028390 scopus 로고    scopus 로고
    • Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate
    • Aime S, Canavese C, Stratta P. Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate. Kidney Int. 2007;72:1162-1163.
    • (2007) Kidney Int , vol.72 , pp. 1162-1163
    • Aime, S.1    Canavese, C.2    Stratta, P.3
  • 27
    • 40949088206 scopus 로고    scopus 로고
    • Gadolinium and nephrogenic systemic fibrosis: The evidence of things not seen
    • Kay J. Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen. Cleve Clin J Med. 2008;75:112-117.
    • (2008) Cleve Clin J Med , vol.75 , pp. 112-117
    • Kay, J.1
  • 28
    • 34347340885 scopus 로고    scopus 로고
    • Perazella MA. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol. 2007;2:200-202.
    • Perazella MA. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol. 2007;2:200-202.
  • 29
    • 0345700639 scopus 로고    scopus 로고
    • Scleromyxoedema-like changes in four renal dialysis patients
    • Hubbard V, Davenport A, Jarmulowicz M, Rustin M. Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol. 2003;148:563-568.
    • (2003) Br J Dermatol , vol.148 , pp. 563-568
    • Hubbard, V.1    Davenport, A.2    Jarmulowicz, M.3    Rustin, M.4
  • 30
    • 33846673048 scopus 로고    scopus 로고
    • The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy: Report of two cases and review of the literature
    • Wahba IM, White K, Mayer M, Simpson EL. The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy: report of two cases and review of the literature. Nephrol Dial Transplant. 2007;22:631-636.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 631-636
    • Wahba, I.M.1    White, K.2    Mayer, M.3    Simpson, E.L.4
  • 31
    • 40449106988 scopus 로고    scopus 로고
    • Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis
    • Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol. 2008;69:161-168.
    • (2008) Clin Nephrol , vol.69 , pp. 161-168
    • Marckmann, P.1    Skov, L.2    Rossen, K.3    Thomsen, H.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.